The role of interleukin-6 as a prognostic biomarker for predicting acute exacerbation in interstitial lung diseases.
<h4>Background</h4>Interstitial lung diseases (ILDs) are chronic, parenchymal lung diseases with a variable clinical course and a poor prognosis. Within various clinical courses, acute exacerbation (AE) is a devastating condition with significant morbidity and high mortality. The aim of...
Guardado en:
Autores principales: | Jae Ha Lee, Ji Hoon Jang, Jin Han Park, Hang-Jea Jang, Chan Sun Park, Sunggun Lee, Seong-Ho Kim, Ji Yeon Kim, Hyun Kuk Kim |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/3ba546534f9944649dc737960238aea9 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Corticosteroid responsiveness in patients with acute exacerbation of interstitial lung disease admitted to the emergency department
por: Hye Jin Jang, et al.
Publicado: (2021) -
Urinary exosome microRNA signatures as a noninvasive prognostic biomarker for prostate cancer
por: Sun Shin, et al.
Publicado: (2021) -
Developmental endothelial locus-1 as a potential biomarker for the incidence of acute exacerbation in patients with chronic obstructive pulmonary disease
por: Dong-Hyun Joo, et al.
Publicado: (2021) -
β-Defensin 2, an Antimicrobial Peptide, as a Novel Biomarker for Ulcerative Interstitial Cystitis; Can β-Defensin 2 Suspect the Dysbiosis of Urine Microbiota?
por: Sang Wook Lee, et al.
Publicado: (2021) -
Albumin inhibits the nuclear translocation of Smad3 via interleukin-1beta signaling in hepatic stellate cells
por: Ji Hoon Park, et al.
Publicado: (2021)